טוען...
Does including machine learning predictions in ALS clinical trial analysis improve statistical power?
OBJECTIVE: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease which leads to progressive muscle weakness and eventually death. The increasing availability of large ALS clinical trial datasets have generated much interest in developing predictive models for disease progression. Howeve...
שמור ב:
| הוצא לאור ב: | Ann Clin Transl Neurol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7545604/ https://ncbi.nlm.nih.gov/pubmed/32862509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.51140 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|